Skip to main content
. Author manuscript; available in PMC: 2010 Apr 19.
Published in final edited form as: Int J Tuberc Lung Dis. 2009 Jul;13(7):855–861.

Table 3. Univariate analysis of predictors of mortality in a treatment cohort of South African XDR-TB patients.

Deceased Number/total
(%)
Survivors Number/total
(%)
P value Univariate Hazard Ratio
(95% CI)
Sex Female 13/25 (52) 21/35 (60) 0.36 0.69 (0.31-1.52)
Age (years) 50+ 2/25 (8) 4/35 (11) 0.66 0.67 (0.11-4.00)
Previous TB Treatment Yes 17/25 (68) 26/35 (74) 0.69 0.78 (0.23-2.67)
Previous MDR-TB Diagnosis Yes 8/25 (32) 14/35 (40) 0.59 0.89 (0.34-2.32)
HIV Infected Yes 18/23 (78) 25/32 (78) 0.90 0.96 (0.52-1.78)
CD4 count (cells/mm3) Less than 200 7/9 (78) 9/20 (45) 0.16 3.07 (0.64-14.79)
On HAART Yes 8/25 (32) 13/35 (37) 0.75 0.87 (0.38-2.02)
Severe AEs* Yes 6/18 (33) 11/32 (34) 0.94 0.94 (0.35-2.51)
*

AEs- Adverse Events